Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Takeda

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
FEBS Letters|September 21, 2012
Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016Yasushi Otani, Takashi Kijima, Satoshi Kohmo, et al.
Translational Lung Cancer Research|October 17, 2022
Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studiesKinnosuke Matsumoto, Takayuki Shiroyama, Tomoki Kuge, et al.
Lung Cancer (Amsterdam, Netherlands)|November 25, 2021
Impact of treatment timing and sequence of immune checkpoint inhibitors and anti-angiogenic agents for advanced non-small cell lung cancer: A systematic review and meta-analysisKinnosuke Matsumoto, Takayuki Shiroyama, Tomoki Kuge, et al.
Scientific Reports|February 23, 2019
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective studyTakayuki Shiroyama, Izumi Nagatomo, Shohei Koyama, et al.
Anticancer Research|August 28, 2024
Stereotactic Ablative Radiotherapy for Early-stage Lung Cancer in Patients With Left Ventricular Assist Device: A Case SeriesKazuhiko Hayashi, Hiroshi Ishikawa, Kei Fujiwara, et al.
Thoracic Cancer|September 15, 2019
Monitoring antibody binding to T cells in a pembrolizumab-treated patient with lung adenocarcinoma on hemodialysisAkio Osa, Takeshi Uenami, Yujiro Naito, et al.
Medicine|January 14, 2022
Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma: A case reportKinnosuke Matsumoto, Takayuki Shiroyama, Kotaro Miyake, et al.
Biochemical and Biophysical Research Communications|May 21, 2017
Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical modelsOsamu Morimura, Toshiyuki Minami, Takashi Kijima, et al.
BMC Pulmonary Medicine|November 5, 2014
Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosisYuhei Kinehara, Hiroshi Kida, Yoshikazu Inoue, et al.
BMC Infectious Diseases|August 7, 2023
Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case reportMaiko Naito, Kentaro Fukushima, Shinsuke Kusakabe, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
FEBS Letters|September 21, 2012
Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016Yasushi Otani, Takashi Kijima, Satoshi Kohmo, et al.
Translational Lung Cancer Research|October 17, 2022
Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studiesKinnosuke Matsumoto, Takayuki Shiroyama, Tomoki Kuge, et al.
Lung Cancer (Amsterdam, Netherlands)|November 25, 2021
Impact of treatment timing and sequence of immune checkpoint inhibitors and anti-angiogenic agents for advanced non-small cell lung cancer: A systematic review and meta-analysisKinnosuke Matsumoto, Takayuki Shiroyama, Tomoki Kuge, et al.
Scientific Reports|February 23, 2019
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective studyTakayuki Shiroyama, Izumi Nagatomo, Shohei Koyama, et al.
Anticancer Research|August 28, 2024
Stereotactic Ablative Radiotherapy for Early-stage Lung Cancer in Patients With Left Ventricular Assist Device: A Case SeriesKazuhiko Hayashi, Hiroshi Ishikawa, Kei Fujiwara, et al.
Thoracic Cancer|September 15, 2019
Monitoring antibody binding to T cells in a pembrolizumab-treated patient with lung adenocarcinoma on hemodialysisAkio Osa, Takeshi Uenami, Yujiro Naito, et al.
Medicine|January 14, 2022
Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma: A case reportKinnosuke Matsumoto, Takayuki Shiroyama, Kotaro Miyake, et al.
Biochemical and Biophysical Research Communications|May 21, 2017
Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical modelsOsamu Morimura, Toshiyuki Minami, Takashi Kijima, et al.
BMC Pulmonary Medicine|November 5, 2014
Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosisYuhei Kinehara, Hiroshi Kida, Yoshikazu Inoue, et al.
BMC Infectious Diseases|August 7, 2023
Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case reportMaiko Naito, Kentaro Fukushima, Shinsuke Kusakabe, et al.
Pageof 15